Supernus Pharmaceuticals | SUPN - Interest Income

Stock Price
49.43
Daily Change
-1.77 -3.46%
Monthly
0.43%
Yearly
47.86%
Q2 Forecast
48.44

Supernus Pharmaceuticals reported $2.02M in Interest Income for its fiscal quarter ending in December of 2025.





Interest Income Change Date
Abbott USD 78M 1000K Dec/2025
Aurora Cannabis CAD 1.85M 120K Sep/2025
Cara Therapeutics USD 347K 74K Mar/2025
Corcept Therapeutics USD 5.42M 399K Dec/2025
Eisai JPY 3.11B 783M Mar/2024
Eli Lilly USD 65M 25M Sep/2025
Pacira USD 2.3M 6.24M Dec/2025
Pfizer USD 115M 51M Mar/2026
Supernus Pharmaceuticals USD 2.02M 254K Dec/2025
United Therapeutics USD 43.2M 3.2M Dec/2025
Xeris Pharmaceuticals USD 1.16M 210K Sep/2025